This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nanjing Sanhome Pharmaceutical Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Wei Sun - Innovator in Medicinal Chemistry
Introduction
Wei Sun is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways. His work focuses on creating innovative solutions for treating diseases mediated by PRMT5.
Latest Patents
Wei Sun holds a patent for a substituted tricyclic compound as a PRMT5 inhibitor. The patent describes a class of compounds that exhibit significant inhibitory activity on PRMT5, which is crucial for various biological processes. The invention includes a compound represented by a specific formula, along with its isomers, pharmaceutically acceptable salts, solvates, crystals, or prodrugs. Additionally, it outlines a preparation method for these compounds and their use in pharmaceutical compositions aimed at treating PRMT5-mediated diseases.
Career Highlights
Wei Sun is associated with Nanjing Sanhome Pharmaceutical Co., Ltd., where he applies his expertise in medicinal chemistry to advance pharmaceutical research and development. His innovative approach has led to the creation of valuable compounds that have the potential to improve therapeutic outcomes for patients.
Collaborations
Wei Sun collaborates with notable colleagues, including Liwen Zhao and Yong Wang. Their combined efforts contribute to the advancement of research in medicinal chemistry and the development of new therapeutic agents.
Conclusion
Wei Sun's work exemplifies the impact of innovative research in the pharmaceutical industry. His contributions to the field of medicinal chemistry, particularly through his patent on PRMT5 inhibitors, highlight the importance of continued innovation in developing effective treatments for complex diseases.